Issued Patents 2017
Showing 1–5 of 5 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| RE46641 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more | 2017-12-19 |
| RE46631 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more | 2017-12-12 |
| 9783787 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 | Stephen S. Whitehead, Lewis Markoff, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more | 2017-10-10 |
| 9707287 | Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein | Stephen S. Whitehead, Kathryn A. Hanley, Joseph E. Blaney, Ching-Juh Lai | 2017-07-18 |
| 9624475 | Genetically stable live attenuated respiratory syncytial virus vaccine and its production | Peter L. Collins, Cindy L. Luongo, Ursula Buchholz | 2017-04-18 |